Forte Biosciences Inc (FBRX) — Financial Flexibility Index
Forte Biosciences Inc (FBRX) has a Financial Flexibility Index of -1.07x as of September 2025. Free cash flow of $-13.95 Million (operating CF $-14.00 Million minus capex $55.00K) represents -1% of total liabilities ($12.99 Million). Also explore Forte Biosciences Inc (FBRX) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Forte Biosciences Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Forte Biosciences Inc across 10 annual periods. Check Forte Biosciences Inc (FBRX) strategic investment index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Forte Biosciences Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Forte Biosciences Inc. For the full company profile including market capitalisation, see Forte Biosciences Inc (FBRX) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -3.38x | $-30.71 Million | $-30.75 Million | $9.08 Million | ▲ +56.7% |
| 2023 | -7.81x | $-28.62 Million | $-28.71 Million | $3.67 Million | ▼ -203.2% |
| 2022 | -2.57x | $-8.19 Million | $-8.19 Million | $3.18 Million | ▲ +72.8% |
| 2021 | -9.45x | $-16.62 Million | $-16.68 Million | $1.76 Million | ▼ -15.9% |
| 2020 | -8.16x | $-18.42 Million | $-18.42 Million | $2.26 Million | ▼ -497.7% |
| 2019 | -1.36x | $-2.61 Million | $-2.77 Million | $1.91 Million | ▼ -88.7% |
| 2018 | -0.72x | $-32.50 Million | $-34.47 Million | $44.94 Million | ▲ +50.2% |
| 2017 | -1.45x | $-30.48 Million | $-31.13 Million | $20.99 Million | ▼ -41.9% |
| 2016 | -1.02x | $-29.01 Million | $-29.54 Million | $28.36 Million | ▼ -13.5% |
| 2015 | -0.90x | $-20.81 Million | $-21.04 Million | $23.09 Million | — |